WARSAW, Ind., October 31, 2018 – Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced U.S. Food and Drug Administration 510(k) clearance of the Persona® Revision Knee System for revision knee replacement procedures. This revision system offers anatomic components designed to match a patient’s unique anatomy for a personalized fit. Available with a modern, intuitive instrumentation platform, the Persona Revision Knee System enables surgeons to take a personalized approach to addressing simple to complex revision procedures by offering the flexibility to utilize their preferred surgical approach.
“Given the complexity of revision procedures and the fact that every person’s anatomy is a little different, it is critical for a knee revision system to give surgeons the ability to personalize the treatment strategy in order to achieve the best outcome for each patient,” said Giles Scuderi, MD, New York, NY.
The Persona Revision Knee System utilizes Zimmer Biomet's proprietary technologies that are designed to enhance optimal fit and function:
“The clearance of the Persona Revision Knee System gives us the ability to provide surgeons with a full service portfolio for the continuum of knee arthroplasty care, from diagnostic tools, cement spacer technologies to re-implantation solutions,” said Todd Davis, Zimmer Biomet’s Vice President & General Manager of the global Knee business. “The Persona Revision Knee System gives surgeons the flexibility to truly tailor an implant solution based on each patient’s unique anatomy for a natural fit and function.”
About Zimmer Biomet
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.
We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information, visitwww.zimmerbiomet.com  or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet .